ATE357235T1 - Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer - Google Patents

Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer

Info

Publication number
ATE357235T1
ATE357235T1 AT03290092T AT03290092T ATE357235T1 AT E357235 T1 ATE357235 T1 AT E357235T1 AT 03290092 T AT03290092 T AT 03290092T AT 03290092 T AT03290092 T AT 03290092T AT E357235 T1 ATE357235 T1 AT E357235T1
Authority
AT
Austria
Prior art keywords
composition
hydrophilic polymer
bioaequivalent
solid dispersion
dispersion containing
Prior art date
Application number
AT03290092T
Other languages
English (en)
Inventor
Pawan Seth
Original Assignee
Cimex Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524260&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357235(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cimex Pharma Ag filed Critical Cimex Pharma Ag
Application granted granted Critical
Publication of ATE357235T1 publication Critical patent/ATE357235T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT03290092T 2003-01-14 2003-01-14 Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer ATE357235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290092.0A EP1438961B2 (de) 2003-01-14 2003-01-14 Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer

Publications (1)

Publication Number Publication Date
ATE357235T1 true ATE357235T1 (de) 2007-04-15

Family

ID=32524260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03290092T ATE357235T1 (de) 2003-01-14 2003-01-14 Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer

Country Status (7)

Country Link
EP (1) EP1438961B2 (de)
AT (1) ATE357235T1 (de)
DE (1) DE60312636T3 (de)
DK (1) DK1438961T4 (de)
ES (1) ES2283725T5 (de)
PT (1) PT1438961E (de)
SI (1) SI1438961T2 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
JP3391801B2 (ja) * 1996-05-20 2003-03-31 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 向上した生物学的利用性を有する抗菌性組成物
FR2758461A1 (fr) † 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
PT969821E (pt) * 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero
CN1153570C (zh) * 1997-12-31 2004-06-16 中外制药株式会社 制备依曲康唑口服制剂的方法及组合物
BR9906712A (pt) † 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
KR100694667B1 (ko) † 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
US6673373B2 (en) † 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same

Also Published As

Publication number Publication date
EP1438961A1 (de) 2004-07-21
SI1438961T1 (sl) 2007-06-30
DK1438961T4 (da) 2014-11-17
PT1438961E (pt) 2007-05-31
DE60312636D1 (de) 2007-05-03
EP1438961B2 (de) 2014-08-20
EP1438961B1 (de) 2007-03-21
ES2283725T3 (es) 2007-11-01
SI1438961T2 (sl) 2014-12-31
DK1438961T3 (da) 2007-07-23
DE60312636T2 (de) 2007-12-06
ES2283725T5 (es) 2014-11-28
DE60312636T3 (de) 2014-12-24

Similar Documents

Publication Publication Date Title
DE602004021107D1 (de) Meloxican-formulierungen in nanoteilchenform
BR0215238A (pt) Uso de nanopartìculas inor ânicas sintéticas como veìculos para drogas oftálmicas e óticas
DE60228252D1 (de) Wasserlösliche blockcopolymere mit einem hydrophilen block und einem hydrophoben block
EP1676556A3 (de) Kosmetische Zusammensetzung, die ein Polyorganosiloxan enthält
EA200701997A1 (ru) Композиция из наночастиц бисфосфоната
ATE457718T1 (de) Sterile gefilterte nanoteilchen-formulierungen von budesonid mit tyloxapol als oberflächenstabilisator
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
ATE417635T1 (de) Knochenzementmischung und röntgenkontrastmittel sowie verfahren zu ihrer herstellung
WO2007005249A3 (en) Nanoparticles and dendritic-polymer-based hydrogels comprising them
ATE343376T1 (de) Nanopartikelzusammensetzungen von angiogeneseinhibitoren
DE60232660D1 (de) Humane dr4-antikörper und deren anwendungen
JP2008538751A5 (de)
DE60204349D1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
DE60305200D1 (de) Aminocyclohexylether-verbindungen und deren verwendung
BR9909189A (pt) Suspensão de agente ativo peroral
DE602005018911D1 (de) 1,4-Dihydropyridine-kondensierte Heterocyclen Verfahren zu deren Herstellung sowie Verwendung und Zusammensetzungen dergleichen
BRPI0511574A (pt) composição, método para depositar um poliéster de açúcar sobre um substrato, e, uso de uma composição
WO2003087165A3 (en) Biocompatible materials and probes
BRPI0401103A (pt) Composição compósita, método para formar a mesma, composição modificada, e, método para formar a mesma
DE60334875D1 (de) Verfahren zur Herstellung von Fluorpolymerzusammensetzungen welche anorganische Nanopartikel enthalten
ATE446742T1 (de) Nanopartikuläre ebastinformulierungen
EA200800092A1 (ru) Композиции в виде наночастиц и с контролируемым высвобождением, включающие арил-гетероциклические соединения
WO2006005611A3 (en) Glucocorticoid 16alpha,17.alpha.-isoxazolidines as anti-inflammatory agents
ATE357235T1 (de) Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1438961

Country of ref document: EP